AbCellera Biologics Inc. - Common Shares — Statistiche Finanziarie Trimestrali (NASDAQ:ABCL)

Financials

Flusso di cassa derivante dalle attività operative -8 M-11.55 M-32.4 M-52.59 M-34.74 M-33.52 M -153.26 M Flussi di cassa derivanti dalle attività di investimento 35.7 M7.93 M-31.81 M36.49 M75.14 M-25.08 M 54.73 M Liquidità derivante dalle attività di finanziamento 4.14 M5.97 M-3.38 M7.37 M4.12 M7.19 M 15.3 M Liquidità libera -8 M-11.55 M-45.77 M-61.52 M-44.59 M-37.35 M -189.23 M

AbCellera Biologics Inc. - Common Shares

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

ABCL

Financials

AbCellera Biologics Inc. - Common Shares

Notizie

After Golden Cross, AbCellera Biologics Inc. (ABCL)'s Technical Outlook is Bright

Truist alza il target su AbCellera grazie ai dati clinici promettenti

Wall Street Analysts Believe ABCELLERA BIOLG (ABCL) Could Rally 97.28%: Here's is How to Trade

Are Medical Stocks Lagging ABCELLERA BIOLG (ABCL) This Year?

AbCellera Biologics Inc. (ABCL) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Cantor alza il target su AbCellera dopo i dati sul farmaco per la menopausa

Stifel alza il target su AbCellera dopo dati positivi dalla sperimentazione

AbCellera Biologics Inc. (ABCL) Q1 2026 Earnings Call Transcript

AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Beats Revenue Estimates

Movimenti after-hours: HIMS, ACHR, HLIT, ABCL, PLUG, BZH, PSIX, ASTS

AbCellera: utili in arrivo con i primi dati clinici

Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates